Onko-Gene

Critical literature watch in the molecular oncology of solid tumors

FREN

Clinical · Molecular biology

Mutations in untranslated non-coding regions of EGFR, AKT1 & HRAS modulate their expression regulatory networks to facilitate progression of colorectal cancer

Summary

This study investigated mutations in the untranslated regions (UTRs) of EGFR, AKT1, and HRAS genes in Pakistani colorectal cancer patients. Whole-exome sequencing and extensive in silico analysis identified several UTR mutations. These alterations demonstrated significant functional impacts, including the loss or gain of transcription factor binding sites, changes in mRNA stability, and the loss of oncomiR binding sites. The findings suggest that these UTR mutations could dysregulate the expression of these oncogenes and contribute to colorectal cancer progression.

Critical appraisal

Clinical. This fundamental research paves the way for identifying novel prognostic or predictive biomarkers based on UTR mutations in colorectal cancer. If these mutations are validated in larger cohorts and correlated with therapeutic response or survival, they could justify clinical trials for personalized therapies targeting the affected pathways. The direct clinical impact is long-term (5+ years), requiring extensive validation studies.

Molecular biology. The study discovered mutations in the UTRs of EGFR, AKT1, and HRAS, demonstrating their ability to modulate gene expression through various mechanisms: altering transcription factor binding sites, modifying mRNA stability, and impacting microRNA binding. Whole-exome sequencing (WES) was the primary technology, complemented by extensive in silico analysis. These discoveries are crucial for understanding post-transcriptional regulation and could lead to the development of new molecular biomarkers for colorectal cancer diagnosis or prognosis, potentially detectable via targeted NGS panels.

Bioinfo & AI. The study heavily relied on in silico analyses to predict the pathogenicity and oncogenicity of the identified UTR mutations. Bioinformatic tools were applied to assess the impact on regulatory elements, mRNA structure, transcription factor binding sites, and miRNA binding sites. Pathway and protein-protein interaction enrichment analyses were also performed to contextualize the genes. This bioinformatic approach is essential for functionally characterizing mutations in non-coding regions, providing a basis for subsequent experimental validation studies.

The summary and the appraisal were written by a language model from the title and abstract of the original article. A curator decided to publish it. Methodology